Health-care companies rose after strong earnings from one major drug maker. Novo Nordisk shares rose sharply after the Danish obesity-drug maker posted fourth-quarter Ozempic sales of $4.71 billion, ...
Clinical-stage biotechnology company Vaxxas has appointed three global vaccine experts as advisors as it progresses its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback